These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38529202)
21. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis. Peng F; Li H; You Q; Li H; Wu D; Jiang C; Deng G; Li Y; Li Y; Wu Y Biomed Res Int; 2017; 2017():5019367. PubMed ID: 28386553 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
23. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994 [TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027 [TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis. Nie G; Lian N; Peng D; Lu J; Li B Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534 [TBL] [Abstract][Full Text] [Related]
27. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
28. Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Rong M; He R; Dang Y; Chen G Ups J Med Sci; 2014 Mar; 119(1):19-24. PubMed ID: 24172202 [TBL] [Abstract][Full Text] [Related]
29. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247 [TBL] [Abstract][Full Text] [Related]
30. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
31. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis. Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653 [TBL] [Abstract][Full Text] [Related]
32. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. Chen L; Jiang M; Yuan W; Tang H J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
35. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3. Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma. Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733 [TBL] [Abstract][Full Text] [Related]
37. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma. Chen F; Li XF; Fu DS; Huang JG; Yang SE Cancer Biomark; 2017; 18(2):209-214. PubMed ID: 27983537 [TBL] [Abstract][Full Text] [Related]
38. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma. Zhang Y; Zhang D; Jiang J; Dong L Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280 [TBL] [Abstract][Full Text] [Related]
39. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis. Hu L; Huang M; Yuan Q; Kong F Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. Li B; Huang P; Qiu J; Liao Y; Hong J; Yuan Y Med Oncol; 2014 Oct; 31(10):230. PubMed ID: 25218269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]